Twist Bioscience News Today

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) has earned a consensus rating of “Buy” from the six research firms that are covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have covered the stock in the last […]

Dimensional Fund Advisors LP increased its stake in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 29.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,267,708 shares of the company’s stock after acquiring an additional 284,884 shares […]

Artisan Partners Limited Partnership raised its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 111.3% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 3,723,305 shares of the company’s stock after acquiring an additional 1,961,621 shares during the period. Artisan Partners Limited Partnership owned 0.06% of Twist Bioscience worth $137,241,000 as of […]

This online drug provider will offer a weight loss drug to rival Novo Nordisk's Ozempic. A Cathie Wood biotech stock also gave back gains.

New workflow to provide unambiguous genetic results in a single assay, alleviating the need for time-consuming and costly follow-up tests Oxford Nanopore Technologies (Oxford Nanopore) today announced

Twist Bioscience presents the Twist cfDNA Library Preparation Kit

Twist Bioscience (NASDAQ:TWST – Free Report) had its price target boosted by Evercore ISI from $46.00 to $50.00 in a report issued on Friday morning, Benzinga reports. Evercore ISI currently has an outperform rating on the stock. Several other brokerages also recently issued reports on TWST. Robert W. Baird lifted their price objective on Twist […]

Twist Bioscience (NASDAQ:TWST – Get Free Report) had its target price lifted by investment analysts at Scotiabank from $43.00 to $48.00 in a report released on Monday, Benzinga reports. The firm presently has a “sector outperform” rating on the stock. Scotiabank’s target price would indicate a potential upside of 7.43% from the company’s current price. […]

Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price target lifted by Scotiabank from $43.00 to $48.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “sector outperform” rating on the stock. Scotiabank’s price objective would indicate a potential upside of 7.43% from the company’s current price. Several other equities […]

Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price objective hoisted by investment analysts at Evercore ISI from $46.00 to $50.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Evercore ISI’s target price would indicate a potential upside of […]